[go: up one dir, main page]

MX2014002744A - Composiciones para el cuidado oral y de la piel con base en un 3,3´-dialquil-1,1´-bifenil-2,2´-diol o un 3,3´-dialquenil-1,1´-bif enil-2,2´-diol. - Google Patents

Composiciones para el cuidado oral y de la piel con base en un 3,3´-dialquil-1,1´-bifenil-2,2´-diol o un 3,3´-dialquenil-1,1´-bif enil-2,2´-diol.

Info

Publication number
MX2014002744A
MX2014002744A MX2014002744A MX2014002744A MX2014002744A MX 2014002744 A MX2014002744 A MX 2014002744A MX 2014002744 A MX2014002744 A MX 2014002744A MX 2014002744 A MX2014002744 A MX 2014002744A MX 2014002744 A MX2014002744 A MX 2014002744A
Authority
MX
Mexico
Prior art keywords
diol
compositions
oral
dialquenil
bifenil
Prior art date
Application number
MX2014002744A
Other languages
English (en)
Other versions
MX348601B (es
Inventor
Ravi Subramanyam
Neelima Utgikar
Guofeng Xu
Ying Yang
Lin Fei
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2014002744A publication Critical patent/MX2014002744A/es
Publication of MX348601B publication Critical patent/MX348601B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen en la presente composiciones que comprenden cantidades antibacterialmente efectivas de un compuesto de la Fórmula (I): (ver Fórmula) o una sal del mismo en la cual R1 y R2 son cada uno independientemente alquilo (C1-C6) o alquenilo (C2-C6), y un portador. Los portadores adecuados incluyen portadores oralmente aceptables, y portadores dermatológicamente aceptables. Las composiciones descritas incluyen composiciones para el cuidado oral y personal útiles para tratar o prevenir afecciones en la piel y orales, respectivamente.
MX2014002744A 2011-09-08 2011-09-08 Composiciones para el cuidado oral y de la piel con base en un 3,3´-dialquil-1,1´-bifenil-2,2´-diol o un 3,3´-dialquenil-1,1´-bif enil-2,2´-diol. MX348601B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/050795 WO2013036229A1 (en) 2011-09-08 2011-09-08 Oral and skin care compositions based on a 3, 3 ' - dialkyl - 1, 1 ' - biphenyl - 2, 2 ' - diol or a 3, 3 ' -dialkenyl- 1, 1 ' -biphenyl- 2, 2 ' -diol

Publications (2)

Publication Number Publication Date
MX2014002744A true MX2014002744A (es) 2014-04-16
MX348601B MX348601B (es) 2017-06-20

Family

ID=44645853

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014002744A MX348601B (es) 2011-09-08 2011-09-08 Composiciones para el cuidado oral y de la piel con base en un 3,3´-dialquil-1,1´-bifenil-2,2´-diol o un 3,3´-dialquenil-1,1´-bif enil-2,2´-diol.

Country Status (15)

Country Link
US (1) US9561193B2 (es)
EP (1) EP2753297B1 (es)
JP (1) JP2014526463A (es)
CN (1) CN103764106B (es)
AR (1) AR087818A1 (es)
AU (1) AU2011376338B2 (es)
BR (1) BR112014005439A2 (es)
CA (1) CA2847694C (es)
MX (1) MX348601B (es)
PH (1) PH12014500414A1 (es)
RU (1) RU2580302C2 (es)
SG (1) SG2014008742A (es)
TW (1) TWI496589B (es)
WO (1) WO2013036229A1 (es)
ZA (1) ZA201401185B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021007084A (es) * 2018-12-18 2021-08-11 Unilever Ip Holdings B V Una composicion antimicrobiana.
CN110668981B (zh) * 2019-09-20 2021-11-19 广东省禾基生物科技有限公司 厚朴酚衍生物及其制备方法与应用
CN112079692B (zh) * 2020-10-29 2023-05-12 中国热带农业科学院环境与植物保护研究所 一种防治植物病原细菌的化合物及其应用
CN118973538A (zh) 2022-04-07 2024-11-15 高露洁-棕榄公司 个人护理组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
KR100509512B1 (ko) 1997-12-31 2005-11-08 삼성전자주식회사 비스(트리알킬트리멜리트산 무수물) 유도체 및 이로부터 형성된 광통신용 폴리에스테르이미드
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) * 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US20030207945A1 (en) * 2001-12-20 2003-11-06 Harper David Scott Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same
US20060024246A1 (en) 2004-07-29 2006-02-02 Prithwiraj Maitra Oral care compositions with film forming polymers
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
CN101223120A (zh) * 2005-02-23 2008-07-16 杰克·L·阿比瑟 用于治疗增殖障碍的和厚朴酚衍生物
KR101001091B1 (ko) 2005-08-25 2010-12-14 콜게이트-파아므올리브캄파니 보습 조성물
CN101883573B (zh) 2007-10-01 2013-03-13 高露洁-棕榄公司 含有植物提取物的口腔组合物
JP5584629B2 (ja) 2008-02-08 2014-09-03 コルゲート・パーモリブ・カンパニー 二構成要素の口腔ケア製品
US9724278B2 (en) 2008-06-13 2017-08-08 Colgate-Palmolive Company Oral compositions and uses thereof
TWI422382B (zh) 2010-02-24 2014-01-11 Colgate Palmolive Co 加強木蘭活性物之溶解度及傳送的組成物

Also Published As

Publication number Publication date
US9561193B2 (en) 2017-02-07
CA2847694A1 (en) 2013-03-14
AR087818A1 (es) 2014-04-16
CN103764106B (zh) 2018-10-19
SG2014008742A (en) 2014-03-28
EP2753297B1 (en) 2017-11-22
US20140234232A1 (en) 2014-08-21
AU2011376338A1 (en) 2014-02-27
TW201323387A (zh) 2013-06-16
CA2847694C (en) 2016-07-26
ZA201401185B (en) 2017-09-27
CN103764106A (zh) 2014-04-30
TWI496589B (zh) 2015-08-21
WO2013036229A1 (en) 2013-03-14
RU2014113535A (ru) 2015-10-20
EP2753297A1 (en) 2014-07-16
BR112014005439A2 (pt) 2017-04-04
JP2014526463A (ja) 2014-10-06
RU2580302C2 (ru) 2016-04-10
AU2011376338B2 (en) 2015-08-27
MX348601B (es) 2017-06-20
PH12014500414A1 (en) 2014-04-14

Similar Documents

Publication Publication Date Title
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
NI201900029A (es) COMPUESTOS DE BENZO[b]TIOFENO COMO AGONISTAS DE STING
CU20110235A7 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
DOP2012000149A (es) Compuestos triciclicos novedosos
CR20150371A (es) Inhibidores de prmt5 y sus usos
MX2020011449A (es) Oxiesteroles y metodos de uso de los mismos.
CR20140301A (es) Derivados de betulina
MX2015008993A (es) Radiofarmaceuticos y agentes de radio-formacion de imagen a base de triazina.
CR20160007A (es) Nuevos compuestos triciclicos
CU20120071A7 (es) DERIVADOS DE N1-PIRAZOLOESPIROCETONA ÚTILES COMO INHIBIDORES DE ACETIL-CoA CARBOXILASA
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
CU20140072A7 (es) Derivados de dihidro-oxazina y dihidro-pirido-oxazina
ECSP12012104A (es) Inhibidores de virus flaviviridae
CR20120418A (es) Inhibidores de virus flaviviridae
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
CU20130126A7 (es) Inhibidores sustituidos de acetil-coa carboxilasa
EA201490272A1 (ru) Новые 4-пиперидинильные соединения для применения в качестве ингибиторов танкиразы
ECSP109919A (es) Compuesto de piridacina cristalina
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
AR084011A1 (es) Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen
UY35551A (es) Derivados heteroarilos como inhibidores de aldosterona sintasa
CO6781541A2 (es) Derivados glucósidos y usos de los mismos
GT201400167A (es) Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2
ECSP10010597A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas

Legal Events

Date Code Title Description
FG Grant or registration